Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Five Hospital Stocks to Buy Now

Page 1 of 2

The second half of 2015 has been tragic for hospital stocks. With concerns of a growing number of uninsured patients who can’t pay their medical bills on the rise, most hospital stocks have been punished heavily in the last few months. The erosion in market capitalization of some of these companies has been so significant that now they are trading at levels last seen in 2012. With this in mind, we have compiled a list of hospital stocks worth buying based on their popularity among hedge funds we follow at the end of the third quarter.

We pay attention to hedge funds’ moves because our research has shown that hedge funds are extremely talented at picking stocks on the long side of their portfolios. It is true that hedge fund investors have been underperforming the market in recent years. However, this was mainly because hedge funds’ short stock picks lost a ton of money during the bull market that started in March 2009. Hedge fund investors also paid an arm and a leg for the services that they received. We have been tracking the performance of hedge funds’ 15 most popular small-cap stock picks in real time since the end of August 2012. These stocks have returned 102% since then and outperformed the S&P 500 Index by around 53 percentage points (see the details here). That’s why we believe it is important to pay attention to hedge fund sentiment; we also don’t like paying huge fees.

#5 Universal Health Services, Inc. (NYSE:UHS)

-Hedge Funds with Long Positions (as of September 30): 44

-Aggregate Value of Hedge Funds’ Holdings (as of September 30): $1.04 billion

Universal Health Services, Inc. (NYSE:UHS)’s stock rose by 30% during the first seven months of the year, but has corrected considerably since then and now trades almost flat for the year. During the third quarter, when the stock dropped by 12%, the number of funds that were long in the company declined by six and the aggregate value of investors’ holdings also saw a drop of over 33%. For the third quarter of fiscal 2015, the company reported EPS of $1.53 on revenue of $2.23 billion versus analysts’ estimate of $1.55 and $2.22 billion, respectively. Billionaire Israel Englander’s Millennium Management reduced its stake in the company by 26% to 827,007 shares during the July-September period.

Follow Universal Health Services Inc (NYSE:UHS)
Trade (NYSE:UHS) Now!

#4 Tenet Healthcare Corp (NYSE:THC)

-Hedge Funds with Long Positions (as of September 30): 44

-Aggregate Value of Hedge Funds’ Holdings (as of September 30): $1.18 billion

Tenet Healthcare Corp (NYSE:THC) has lost more than half of its market capitalization since the start of second-half of 2015. However, it suffered only a minor drop in popularity among hedge funds during the third quarter with the number of funds long the stock having declined by four during the third quarter. On December 16, analysts at Credit Suisse initiated coverage on Tenet Healthcare Corp (NYSE:THC)’s stock with a ‘Neutral’ rating and a $33 price target. Larry Robbins‘ Glenview Capital – which was the largest shareholder of the company at the end of third quarter – has been making full use of the decline in Tenet Healthcare Corp’s stock during the fourth quarter by purchasing more shares; it holds almost 17.9 million shares of the company, according to its latest SEC filings.

Follow Tenet Healthcare Corp (NYSE:THC)
Trade (NYSE:THC) Now!

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!